Search   
MSDS  : 3H-1,4-Benzodiazepine, 7-chloro-2-(methylamino)-5-phenyl-, 4-oxide
CAS  : 58-25-3
SYNONYMS  : * Balance * 3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide * CDO * Chlordiazepoxide * 7-Chlor-2-methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxid * Chlorodiazepoxide * 7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine 4-oxide * Chlozepid * Clopoxide * Clordiazepossido * 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido * Control * Decacil * EDEN * Elenium * Ifibrium * Kalmocaps * Librinin * Mesural * Methaminodiazepoxide * Mildmen * Napoton * Psicosan * Radepur * Viopsicol
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : DE9275000
CHEMICAL NAME : 3H-1,4-Benzodiazepine,
7-chloro-2-(methylamino)-5-phenyl-, 4-oxide
CAS REGISTRY NUMBER : 58-25-3
LAST UPDATED : 199712
DATA ITEMS CITED : 48
MOLECULAR FORMULA : C16-H14-Cl-N3-O
MOLECULAR WEIGHT : 299.78
WISWESSER LINE NOTATION : T67 GN JN IHJ CG HM1 JO KR
COMPOUND DESCRIPTOR : Drug
Mutagen
Reproductive Effector
Human
SYNONYMS/TRADE NAMES :
* Balance
* 3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide
* CDO
* Chlordiazepoxide
* 7-Chlor-2-methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxid
* Chlorodiazepoxide
* 7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine 4-oxide
* Chlozepid
* Clopoxide
* Clordiazepossido
* 7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido
* Control
* Decacil
* EDEN
* Elenium
* Ifibrium
* Kalmocaps
* Librinin
* Mesural
* Methaminodiazepoxide
* Mildmen
* Napoton
* Psicosan
* Radepur
* Viopsicol

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 4 mg/kg
TOXIC EFFECTS :
Behavioral - euphoria
Behavioral - somnolence (general depressed activity)
Behavioral - antianxiety
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
3,619,1961

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human
DOSE/DURATION : 857 ug/kg
TOXIC EFFECTS :
Behavioral - sleep
REFERENCE :
DMBUAE Danish Medical Bulletin. (Copenhagen, Denmark) V.1-18, 1954-71.
Volume(issue)/page/year: 13,170,1966

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human
DOSE/DURATION : 2 mg/kg/2D
TOXIC EFFECTS :
Behavioral - sleep
Behavioral - ataxia
REFERENCE :
JLSMAW Journal of the Louisiana State Medical Society. (New Orleans, LA)
V.105-134, 1953-82. Volume(issue)/page/year: 112,142,1960

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 104 mg/kg/4D-C
TOXIC EFFECTS :
Behavioral - coma
Vascular - BP elevation not characterized in autonomic section
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
JTCTDW Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270
Madison Ave., New York, NY 10016) V.19- 1982- Volume(issue)/page/year:
27,117,1989

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 392 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9,
Washington, DC 20231) Volume(issue)/page/year: #3794726

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 143 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 17,242,1967

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >800 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CTCEA9 Current Therapeutic Research, Clinical & Experimental. (Therapeutic
Research Press, Inc., POB 514, Tenafly, NJ 07670) V.1- 1959-
Volume(issue)/page/year: 7,590,1965

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 165 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CTCEA9 Current Therapeutic Research, Clinical & Experimental. (Therapeutic
Research Press, Inc., POB 514, Tenafly, NJ 07670) V.1- 1959-
Volume(issue)/page/year: 7,590,1965

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9,
Washington, DC 20231) Volume(issue)/page/year: #3966793

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 80 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9,
Washington, DC 20231) Volume(issue)/page/year: #3966793

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 392 mg/kg
TOXIC EFFECTS :
Behavioral - anticonvulsant
REFERENCE :
APTOA6 Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59,
1945-86. For publisher information, see PHTOEH Volume(issue)/page/year:
19,247,1962

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 95 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-
1898- Volume(issue)/page/year: 178,216,1969

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 366 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,248,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Parenteral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 700 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9,
Washington, DC 20231) Volume(issue)/page/year: #5010077

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 590 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-
1898- Volume(issue)/page/year: 178,216,1969

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 2650 mg/kg/30D-I
TOXIC EFFECTS :
Blood - changes in erythrocyte (RBC) count
Blood - changes in leukocyte (WBC) count
Biochemical - Metabolism (Intermediary) - lipids including transport
REFERENCE :
AGSOA6 Agressologie. Revue Internationale de Physio-Biologie et de
Pharmacologie Appliquees aux Effets de l'Agression. (SPPIF, B.P.22, F-41353
Vineuil, France) V.1- 1960- Volume(issue)/page/year: 22,209,1981

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 7 gm/kg/5W-C
TOXIC EFFECTS :
Liver - other changes
Kidney, Ureter, Bladder - other changes
Blood - other changes
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 6,2228,1972

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 9100 mg/kg/26W-C
TOXIC EFFECTS :
Liver - other changes
Kidney, Ureter, Bladder - other changes
Blood - other changes
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 6,2228,1972

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 14112 mg/kg/56W-C
TOXIC EFFECTS :
Gastrointestinal - changes in pancreatic weight
Liver - changes in liver weight
Kidney, Ureter, Bladder - changes in bladder weight
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
16,556,1970

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - man
DOSE : 286 ug/kg
SEX/DURATION : male 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - impotence
REFERENCE :
AJPSAO American Journal of Psychiatry. (American Psychiatric Assoc.,
Circulation Dept., 1400 K St., NW, Washington, DC 20005) V.78- 1921-
Volume(issue)/page/year: 121,610,1964

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 3520 ug/kg
SEX/DURATION : lactating female 16 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - behavioral
REFERENCE :
49DWAS "Application of Behavioral Pharmacology in Toxicology, Lectures of
the Workshop, 1982," Zhinden, G., et al., eds., New York, Raven Press, 1983
Volume(issue)/page/year: -,217,1983

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 525 mg/kg
SEX/DURATION : female 1-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4
per # born alive)
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
48,A120,1979

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 525 mg/kg
SEX/DURATION : female 1-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
Reproductive - Effects on Newborn - live birth index (measured after birth)
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
48,A120,1979

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 120 mg/kg
SEX/DURATION : female 5-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
RCOCB8 Research Communications in Chemical Pathology and Pharmacology. (PJD
Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970-
Volume(issue)/page/year: 7,701,1974

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 4400 ug/kg
SEX/DURATION : lactating female 20 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
49DWAS "Application of Behavioral Pharmacology in Toxicology, Lectures of
the Workshop, 1982," Zhinden, G., et al., eds., New York, Raven Press, 1983
Volume(issue)/page/year: -,217,1983

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE : 21 mg/kg
SEX/DURATION : female 1-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
Reproductive - Effects on Newborn - behavioral
REFERENCE :
NTOTDY Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8,
1981-86. For publisher information, see NETEEC. Volume(issue)/page/year:
4,279,1982

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE : 21 mg/kg
SEX/DURATION : lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
Reproductive - Effects on Newborn - behavioral
REFERENCE :
NTOTDY Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8,
1981-86. For publisher information, see NETEEC. Volume(issue)/page/year:
4,279,1982

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE : 20 mg/kg
SEX/DURATION : female 13-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
Reproductive - Effects on Newborn - behavioral
REFERENCE :
IJEBA6 Indian Journal of Experimental Biology. (Publications & Information
Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-
Volume(issue)/page/year: 32,184,1994

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 936 mg/kg
SEX/DURATION : female 26 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - parturition
REFERENCE :
RCOCB8 Research Communications in Chemical Pathology and Pharmacology. (PJD
Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970-
Volume(issue)/page/year: 11,155,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 2484 mg/kg
SEX/DURATION : male 5 day(s) pre-mating
female 3 week(s) pre-mating - 3 week(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - weaning or lactation index (e.g., #
alive at weaning per # alive at day 4)
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
PLRCAT Pharmacological Research Communications. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1969- Volume(issue)/page/year:
9,187,1977

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 6 gm/kg
SEX/DURATION : male 5 day(s) pre-mating
female 15 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - mating performance (e.g. # sperm positive females
per # females mated; # copulations per # estrus cycles)
REFERENCE :
RCOCB8 Research Communications in Chemical Pathology and Pharmacology. (PJD
Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970-
Volume(issue)/page/year: 13,601,1976

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 756 mg/kg
SEX/DURATION : female 1-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - behavioral
REFERENCE :
PLRCAT Pharmacological Research Communications. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1969- Volume(issue)/page/year:
9,325,1977

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE : 150 mg/kg
SEX/DURATION : female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
DGDFA5 Development, Growth & Differentiation. (Japan Pub. Trading Co.
(USA), 1255 Howard St., San Francisco, CA 94103) V.11- 1969-
Volume(issue)/page/year: 22,61,1980

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 280 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
REFERENCE :
LIFSAK Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park,
Elmsford, NY 10523) V.1-8, 1962-69; V.14- 1974- Volume(issue)/page/year:
29,2141,1981

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 2410 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
REFERENCE :
LIFSAK Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park,
Elmsford, NY 10523) V.1-8, 1962-69; V.14- 1974- Volume(issue)/page/year:
29,2141,1981

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 3100 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
LIFSAK Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park,
Elmsford, NY 10523) V.1-8, 1962-69; V.14- 1974- Volume(issue)/page/year:
29,2141,1981

** MUTATION DATA **

TYPE OF TEST : Micronucleus test
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 40 mg/kg/24H
REFERENCE :
CARYAB Caryologia. (Via G. LaPira 4, 50121 Florence, Italy) V.1- 1948-
Volume(issue)/page/year: 39,193,1986

TYPE OF TEST : Cytogenetic analysis
ROUTE OF EXPOSURE : Unreported
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 400 mg/kg
REFERENCE :
CYGEDX Cytology and Genetics (English Translation). Translation of TGANAK.
(Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974-
Volume(issue)/page/year: 10(4),72,1976

TYPE OF TEST : Cytogenetic analysis
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 20 mg/kg
REFERENCE :
CYTBAI Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969-
Volume(issue)/page/year: 36,73,1983

TYPE OF TEST : Dominant lethal test
ROUTE OF EXPOSURE : Unreported
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 400 mg/kg
REFERENCE :
CYGEDX Cytology and Genetics (English Translation). Translation of TGANAK.
(Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974-
Volume(issue)/page/year: 10(4),72,1976

TYPE OF TEST : Sperm Morphology
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 300 mg/kg/15D (Continuous)
REFERENCE :
CYTBAI Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969-
Volume(issue)/page/year: 36,45,1983

*** REVIEWS ***

TOXICOLOGY REVIEW
DNSYAG Diseases of the Nervous System. (Memphis, TN) V.1-38, 1940-77. For
publisher information, see JCLPDE. Volume(issue)/page/year: 36,23,1975

TOXICOLOGY REVIEW
CLANA4 Clinical Anesthesia. (Philadelphia, PA 19103) V.1-11, 1963-76.
Volume(issue)/page/year: 10(Pt 1),207,1973

TOXICOLOGY REVIEW
INTEAG Internist. (Springer-Verlag New York, Inc., Service Center, 44 Hartz
Way, Secaucus, NJ 07094) V.1- 1960- Volume(issue)/page/year: 15,7,1974

TOXICOLOGY REVIEW
CLCHAU Clinical Chemistry (Winston-Salem, NC). (American Assoc. for
Clinical Chemistry, 1725 K St., NW, Washington, DC 20006) V.1- 1955-
Volume(issue)/page/year: 19,361,1973

*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - X3598
No. of Facilities: 22 (estimated)
No. of Industries: 1
No. of Occupations: 2
No. of Employees: 480 (estimated)
No. of Female Employees: 358 (estimated)

*** STATUS IN U.S. ***

EPA GENETOX PROGRAM 1988, Negative: S cerevisiae gene conversion

EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
1H-1,4-Benzodiazepine-1-carboxamide,2,3-dihydro-N-methyl-7-nitro-2-oxo-5-phenyl- 27016-91-7
1H-1,5-Benzodiazepine-1-carboxamide,2,3,4,5-tetrahydro-2-methyl-4-oxo- 89647-50-7
1H-1,4-Benzodiazepine-3-carboxylic acid,7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassiumsalt, compd. with potassium hydroxide 57109-90-7
1H-1,4-Benzodiazepine-3-carboxylic acid,7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, ethylester 29177-84-2
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-5-(2-chlorophenyl)-1-((methylamino)carbonyl)-2-oxo-, ethyl ester 65400-84-2
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-5-(2-fluorophenyl)-1-((methylamino)carbonyl)-2-oxo-, ethyl ester 65400-85-3
5H-Benzocyclohepten-7-amine, 6,7-dihydro-N-methyl-,hydrochloride, (+)- 62819-45-8
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-2-oxo-5-phenyl-, monopotassiumsalt 5991-71-9
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-2-oxo-5-phenyl-, phenyl ester 5991-71-9
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-nitro-2-oxo-5-phenyl-, monopotassiumsalt 5571-84-6
1H-1,5-Benzodiazepine-2-carboxylic acid,5,5'-(1,2-dioxo-1,2-ethanediyl)bis(2,3,4,5-tetrahydro-2-methyl-4-phenyl-, diethyl ester 144401-02-5
1H-1,4-Benzodiazepine-3-carboxylic acid,2-hydroxy-7-nitro-5-phenyl-, monopotassium salt,compd. with potassium hydroxide 24477-47-2
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-acetyl-4-methyl-, ethyl ester 121635-52-7
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-acetyl-2-methyl-4- phenyl-,ethyl ester 92911-27-8
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-benzoyl-4-methyl-, ethyl ester 121635-55-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-benzoyl-2-methyl-4- phenyl-,ethyl ester 92942-83-1
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-((bis(2-methylpropyl)amino)acetyl)-4-methyl-, ethyl ester 121635-59-4
5H-Benzocyclohepten-7-amine,6,7-dihydro-N-methyl-9-phenyl-, hydrochloride 62819-50-5
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-(chloroacetyl)-4-methyl-, ethylester 121635-53-8
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-(chloroacetyl)-2-methyl-4-phenyl-, ethyl ester 92911-28-9
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-(4-chlorobenzoyl)-4-methyl-,ethyl ester 121635-56-1
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-(4-chlorobenzoyl)-2-methyl-4-phenyl-, ethyl ester 92911-29-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-((diethylamino)acetyl)-4-methyl-, ethyl ester 121635-57-2
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-((dipropylamino)acetyl)-4-methyl-, ethyl ester 121635-58-3
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-, ethyl ester 87896-36-4
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-5-(4-morpholinylacetyl)-,ethyl ester 121635-60-7
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-5-(1-oxobutyl)-, ethylester 121635-54-9
1H-1,5-Benzodiazepine-1-carboxylic acid,2,3,4,5-tetrahydro-2-methyl-4-oxo-, ethyl ester 98987-10-1
5H-Benzocyclohepten-7-amine,6,7-dihydro-N-2-propenyl-, hydrochloride 62819-69-6
1H-1,5-Benzodiazepine-5-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-2-oxo-, methyl ester 89647-48-3
1H-1,5-Benzodiazepine-1-carboxylic acid,2,3,4,5-tetrahydro-2-methyl-4-oxo-, phenyl ester 98987-11-2
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-2-methyl-5-(1-oxo-3-phenyl-2-propentyl)-4-phenyl-, ethyl ester 144401-01-4
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-2-methyl-4-phenyl-, ethyl ester 87918-91-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-2-methyl-4-phenyl-5-(1-oxopropyl)-, ethyl ester 92942-82-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-5-(1-piperidinylacetyl)-,ethyl ester 121635-61-8
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-phenyl- 87896-33-1
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-phenyl-, ethyl ester 87896-35-3
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-phenyl-, methyl ester 87896-34-2
3H-1,4-Benzodiazepine,7-chloro-2-(cyclopropylamino)-5-phenyl-, 4-oxide 3864-80-0
5H-Benzocyclohepten-7-amine,6,7,8,9-tetrahydro-5-(4-aminophenoxy)-N,N-dimethyl-,dihydrochloride, cis- 72575-47-4
3H-1,4-Benzodiazepine,7-chloro-2-((cyclopropylmethyl)amino)-5-phenyl-,4-oxide 15687-07-7
1H-1,4-Benzodiazepine,7-chloro-2,3-dihydro-1-methyl-5-phenyl- 2898-12-6
1H-1,4-Benzodiazepine,7-chloro-2,3-dihydro-1-methyl-5-phenyl-,monohydrochloride 2898-11-5
1H-1,4-Benzodiazepine, 7-chloro-2,3-dihydro-5-phenyl 1694-78-6
3H-1,4-Benzodiazepine,7-chloro-2-dimethylamino-5-phenyl-, 4-oxide 3693-14-9
3H-1,4-Benzodiazepine,7-chloro-2-(N-methoxymethyl-N-methylamino)-5-phenyl-,4-oxide 69353-35-1
3H-1,4-Benzodiazepine,7-chloro-2-(methylamino)-5-phenyl-, 4-oxide 58-25-3
3H-1,4-Benzodiazepine,7-chloro-2-(methylamino)-5-phenyl-, 4-oxide andbarbituric acid, 5-ethyl-5-phenyl- (5:3) 63917-56-6
3H-1,4-Benzodiazepine,7-chloro-2-methylamino-5-phenyl-, 4-oxide,monohydrochloride 438-41-5
3H-1,4-Benzodiazepine,7-chloro-2-methylamino-5-phenyl-, 4-oxide, mixed withsodium nitrite (1:1) 104639-49-8

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net